Wang, Wei

Biography

Education 2009   Ph.D., Pharmaceutics, China Pharmaceutical University 2006   M.S., Pharmacology, China Pharmaceutical University 2003   B.S., Pharmacy, China Pharmaceutical University Academic Experience 2014-2015  Visiting Scholar of Pharmaceutics, University of North Carolina at Chapel Hill (UNC) 2012- Associate Professor of Pharmaceutics, China Pharmaceutical University 2009-2012  Lecturer of Pharmaceutics, China Pharmaceutical University Awards and Honors 2014  The Youth Pharmaceutical Scientist Award, Chinese Pharmaceutical Association (CPA) 2013  The Chief Expert, Jiangsu Association for Science and Technology (JAST) 2012 The Drug Pricing Evaluation Expert, National Development and Reform Commission (NDRC)

Research Interest

Professor WANG’s research focuses on the the studies of nanovector based delivery system for biomacromolecular drugs and nanoscale targeted drug delivery system. He recently published a paper entitled "A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy", which considered that combining DCA and p53 gene could be an effective way to treat tumors and developed a DSPE-PEG-AA modified reconstituted high-density lipoprotein-based DCA/p53-loaded nanoparticles, which are fabricated as a drug/gene dual-targeting co-delivery system for potential cancer therapy.